Venture Beyond
Section 32 is a venture capital fund investing at the frontiers of technology, healthcare and the life sciences.
CUMULATIVE TEAM EXPERIENCE
The team members have been founders, operators and investors in companies that have challenged the status quo, enhanced the human experience, and improved human health globally.
Companies
M&A
IPOs
$1B Valuations
Recent investments are clustered around biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.
Section 32 invests in curious and determined scientists, engineers and designers who are tackling seemingly impossible-to-solve problems with a clear view on how the world should work.
Exits
Crowdstrike
IPO 6.11.19
Auris
Acquired by JNJ
Alector
IPO 2.7.19
Fulcrum Therapeutics
IPO 7.17.19
